Skip to main content
Top

Cancer Causes & Control

Issue 5/2005

Content (16 Articles)

Hormone replacement therapy is not associated with an increased risk of leukemia (United States)

Julie A. Ross, Penny J. Sinner, Cindy K. Blair, James R. Cerhan, Aaron R. Folsom

Lifestyle factors and the risk of adult leukemia in Canada

Khaled Kasim, Patrick Levallois, Belkacem Abdous, Pierre Auger, Kenneth C. Johnson

Social inequalities and cancer mortality in France, 1975–1990

Gwenn Menvielle, Danièle Luce, Béatrice Geoffroy-Perez, Jean-François Chastang, Annette Leclerc

Occupational class, occupational mobility and cancer incidence among middle-aged men and women: a prospective study of the French GAZEL cohort*

Maria Melchior, Marcel Goldberg, Nancy Krieger, Ichiro Kawachi, Gwenn Menvielle, Marie Zins, Lisa F. Berkman

Adipose levels of dioxins and risk of breast cancer

Peggy Reynolds, Susan E. Hurley, Myrto Petreas, Debbie E. Goldberg, Daniel Smith, Debra Gilliss, M. Ellen. Mahoney, Stefanie S. Jeffrey

Life After Cancer Epidemiology (LACE) Study: A cohort of early stage breast cancer survivors (United States)

Bette Caan, Barbara Sternfeld, Erica Gunderson, Ashley Coates, Charles Quesenberry, Martha L. Slattery

A case for informed consent? Indoor UV tanning facility operator’s provision of health risks information (United States)

Lauren F. Heilig, Renee D’Ambrosia, Amanda L. Drake, Robert P. Dellavalle, Eric J. Hester

C-peptide, IGF-I, sex-steroid hormones and adiposity: a cross-sectional study in healthy women within the European Prospective Investigation into Cancer and Nutrition (EPIC)

Irene D. Bezemer, Sabina Rinaldi, Laure Dossus, Carla H. van. Gils, Petra H. M. Peeters, Paulus A. H. van. Noord, H. Bas Bueno-de-Mesquita, Soren Paaske Johnsen, Kim Overvad, Anja Olsen, Anne Tjønneland, Heiner Boeing, Petra H. Lahmann, Jakob Linseisen, Gabriele Nagel, Naomi Allen, Andrew Roddam, Sheila Bingham, Kay-Tee Khaw, Emmanuelle Kesse, Bertrand Téhard, Françoise Clavel-Chapelon, Antonio Agudo, Eva Ardanaz, J. R. Quiros, Pilar Amiano, Martínez-Garcia C, M. J. Tormo, Valeria Pala, Salvatore Panico, Paolo Vineis, Domenico Palli, Rosario Tumino, Antonia Trichopoulou, N. Baibas, D. Zilis, Bertrand Hémon, Teresa Norat, Elio Riboli, Rudolf Kaaks

Secular trends in the incidence, mortality, and survival rate of gastric cancer in a general Japanese population: the Hisayama study

Keiichi Tanaka, Yutaka Kiyohara, Michiaki Kubo, Takayuki Matsumoto, Yumihiro Tanizaki, Ken Okubo, Toshiharu Ninomiya, Yoshinori Oishi, Kentaro Shikata, Mitsuo Iida

Risk of non-small cell lung cancer and the cytochrome P4501A1 Ile462Val polymorphism

Jill Everland Larsen, Maree Louise Colosimo, Ian Anthony Yang, Rayleen Bowman, Paul Victor Zimmerman, Kwun Meng Fong

Pediatric brain tumors in Non-Hispanics, Hispanics, African Americans and Asians: differences in survival after diagnosis

Jill S. Barnholtz-Sloan, Richard K. Severson, Bonita Stanton, Merlin Hamre, Andrew E. Sloan

Risk of non-Hodgkin lymphoma associated with occupational exposure to solvents, metals, organic dusts and PCBs (Australia)

Lin Fritschi, Geza Benke, Ann M. Hughes, Anne Kricker, Claire M. Vajdic, Andrew Grulich, Jennifer Turner, Samuel Milliken, John Kaldor, Bruce K. Armstrong

Antioxidants and basal cell carcinoma of the skin: A nested case–control study

Sarah A. McNaughton, Geoffrey C. Marks, Philip Gaffney, Gail Williams, Adele C. Green

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine